Publication

Lou E, Xiu J, Baca Y, Saeed A, Prakash A, Gholami S, Subramanian S, Starr TK, Fontana E, Pandey R, et al. 2024. Differential landscape of immune evasion in oncogenic RAS-driven primary and metastatic colorectal cancers. Molecular Therapy: Oncology. 32(1):200786.

Arshad J, Rao A, Repp ML, Rao R, Wu C, Merchant JL. 2024. Myeloid-Derived Suppressor Cells: Therapeutic Target for Gastrointestinal Cancers. International Journal of Molecular Sciences. 25(5):2985. doi:10.3390/ijms25052985.

Gunning JA, Gilman KE, Zúñiga TM, Simpson RJ, Limesand KH. 2024. Parotid glands have a dysregulated immune response following radiation therapy. Fujiwara K, editor. PLOS ONE. 19(3):e0297387. doi:10.1371/journal.pone.0297387.

Block Ngaybe MG, Ravi P, Rosales A, Camarena JL, Madhivanan P. 2024. Systematic review study protocol of literature from 2018 to end of 2022 of stated preference studies about HIV care and prevention services around the world. BMJ Open. 14(3):e072661. doi:10.1136/bmjopen-2023-072661.

Buller DB, Sussman AL, Thomson CA, Kepka D, Taren D, Henry KL, Warner EL, Walkosz BJ, Woodall WG, Nuss K, et al. 2024. #4Corners4Health Social Media Cancer Prevention Campaign for Emerging Adults: Protocol for a Randomized Stepped-Wedge Trial. JMIR Research Protocols. 13:e50392. doi:10.2196/50392.

Valencia CI, Wightman P, Morrill KE, Hsu C, Arif‐Tiwari H, Kauffman E, Gachupin FC, Chipollini J, Lee BR, Garcia DO, et al. 2024. Neighborhood social vulnerability and disparities in time to kidney cancer surgical treatment and survival in Arizona. Cancer Medicine. 13(3). doi:10.1002/cam4.7007.

Coffee Z, Hsu C-H, Vanderah TW, Gordon JS. 2024. Predictors of Enrollment and Adherence in a Randomized Tobacco Cessation Clinical Trial. Tobacco Use Insights. 17. doi:10.1177/1179173x241308136.

Xiao Y, Zhang X, Li Y, Shi G, Krunz M, Nguyen DN, Hoang DT. 2024. Time-Sensitive Learning for Heterogeneous Federated Edge Intelligence. IEEE Transactions on Mobile Computing. 23(2):1382–1400. doi:10.1109/tmc.2023.3237374.

Fu Z, Tseng HW, Vedantham S. 2024. An attenuation field network for dedicated cone beam breast CT with short scan and offset detector geometry. Scientific Reports. 14(1). doi:10.1038/s41598-023-51077-1.

Bradshaw CM, Georgieva T, Tankersley TN, Taylor-Doyle T, Johnson L, Uhrlaub JL, Besselsen D, Nikolich JŽ. 2024. Cutting Edge: Characterization of Low Copy Number Human Angiotensin-Converting Enzyme 2–Transgenic Mice as an Improved Model of SARS-CoV-2 Infection. The Journal of Immunology. 212(4):523–528. doi:10.4049/jimmunol.2300591.

Quaid M, Goodrich JM, Calkins MM, Graber JM, Urwin D, Gabriel J, Caban‐Martinez AJ, Petroff RL, Grant C, Beitel SC, et al. 2024. Firefighting, per‐ and polyfluoroalkyl substances, and DNA methylation of genes associated with prostate cancer risk. Environmental and Molecular Mutagenesis. 65(1–2):55–66. doi:10.1002/em.22589.

Nawrocki ST, Espitia C, Carrera Espinoza MJ, Jones TM, Gamble ME, Sureshkumar S, Chang M, Wang W, Carew JS. 2024. Inhibition of autophagy antagonizes breast cancer brain metastogenesis and augments the anticancer activity of lapatinib. Clinical and Translational Medicine. 14.

Buss LG, Rheinheimer BA, Limesand KH. 2024. Radiation-induced changes in energy metabolism result in mitochondrial dysfunction in salivary glands. Scientific Reports. 14(1). doi:10.1038/s41598-023-50877-9.

Duan S, Sawyer TW, Witten BL, Song H, Else T, Merchant JL. 2024. Spatial profiling reveals tissue‐specific neuro‐immune interactions in gastroenteropancreatic neuroendocrine tumors. The Journal of Pathology. 262(3):362–376. doi:10.1002/path.6241.

Zhang W, Krunz M, Ditzler G. 2024. Stealthy Adversarial Attacks on Machine Learning-Based Classifiers of Wireless Signals. IEEE Transactions on Machine Learning in Communications and Networking. 2:261–279. doi:10.1109/tmlcn.2024.3366161.

Osipov A, Nikolic O, Gertych A, Parker S, Hendifar A, Singh P, Filippova D, Dagliyan G, Ferrone CR, Zheng L, et al. 2024. The Molecular Twin artificial-intelligence platform integrates multi-omic data to predict outcomes for pancreatic adenocarcinoma patients. Nature Cancer. 5(2):299–314.

Herbst-Kralovetz MM, Flores M, Bishop N, Jimenez N, Mancilla V. 2024. The Vaginal Microbiota, Human Papillomavirus Infection, and Cervical Carcinogenesis: A Systematic Review in the Latina Population. Journal of Epidemiology and Global Health. doi:https://doi.org/10.1007/s44197-024-00201-z.

Andrews JA, Gordon JS, Westling E, Smith D. 2023. Assessing the Pragmatic Effectiveness and Implementation of Click City: Tobacco: A School-Based Prevention Program Targeting Youth Cigarette and E-cigarette Use. Nicotine and Tobacco Research. 26(7):861–869. doi:10.1093/ntr/ntad244.

Werner AN, Kumar AI, Charest PG. 2023. CRISPR-mediated reversion of oncogenic KRAS mutation results in increased proliferation and reveals independent roles of Ras and mTORC2 in the migration of A549 lung cancer cells. Welch M, editor. Molecular Biology of the Cell. 34(13). doi:10.1091/mbc.e23-05-0152.

Cecil JH, Padilla CM, Lipinski AA, Langlais PR, Luo X, Capaldi AP. 2023 Dec. The Molecular Logic of Gtr1/2 and Pib2 Dependent TORC1 Regulation in Budding Yeast. doi:10.1101/2023.12.06.570342.

Marr KD, Gard JM, Harryman WL, Keeswood EJ, Paxson AI, Wolgemuth C, Knudsen BS, Nagle RB, Hazlehurst L, Sorbellini M, et al. 2023. Biophysical phenotype mixtures reveal advantages for tumor muscle invasion in vivo. Biophysical Journal. 122(21):4194–4206. doi:10.1016/j.bpj.2023.09.016.

Buss LG, de Oliveira Pessoa D, Snider JM, Padi M, Martinez JA, Limesand KH. 2023. Metabolomics analysis of pathways underlying radiation-induced salivary gland dysfunction stages. Yu ET, editor. PLOS ONE. 18(11):e0294355. doi:10.1371/journal.pone.0294355.

Paxson AI, Chang LH, Gard JMC, Harryman WL, Nelson CS, Salmon SB, Marr KD, Wachsmuth LM, Ramanathan A, Ran J, et al. 2023. Phenotype plasticity and altered sensitivity to chemotherapeutic agents in aggressive prostate cancer cells. Frontiers in Cell and Developmental Biology. 11. doi:10.3389/fcell.2023.1285372.

Wang Z, Li W, Jiang Y, Tran TB, Cordova LE, Chung J, Kim M, Wondrak G, Erdrich J, Lu J. 2023. Sphingomyelin-derived nanovesicles for the delivery of the IDO1 inhibitor epacadostat enhance metastatic and post-surgical melanoma immunotherapy. Nature Communications. 14(1). doi:10.1038/s41467-023-43079-4.

Chopp LB, Zhu X, Gao Y, Nie J, Singh J, Kumar P, Young KZ, Patel S, Li C, Balmaceno-Criss M, et al. 2023. Zfp281 and Zfp148 control CD4 + T cell thymic development and T H 2 functions. Science Immunology. 8(89). doi:10.1126/sciimmunol.adi9066.